Monetary Value of Quality-Adjusted Life Years (QALY) among Patients with Cardiovascular Disease: a Willingness to Pay Study (WTP)

Simple item page
AuthorNajmeh Moradien
AuthorArash Rashidianen
AuthorHamid Reza Rasekhen
AuthorAlireza Olyaeemaneshen
AuthorMahnoosh Foroughien
AuthorTeymoor Mohammadien
Issued Date2017-04-30en
AbstractThe aim of this study was to estimate the monetary value of a QALY among patients with heart disease and to identify its determinants. A cross-sectional survey was conducted through face-to-face interview on 196 patients with cardiovascular disease from two heart hospitals in Tehran, Iran, to estimate the value of QALY using disaggregated and aggregated approaches. The EuroQol-5 Dimension (EQ-5D) questionnaire, Visual Analogue Scale (VAS), Time Trade-Off (TTO) and contingent valuation WTP techniques were employed, first to elicit patients’ preferences and then, to estimate WTP for QALY. The association of patients’ characteristics with WTP for QALY, was assessed through Heckman selection model. The Mean willingness to pay per QALY, estimated by the disaggregated approach ranged from 2,799 to 3599 US dollars. It is higher than the values, estimated from aggregated methods (USD 2,256 to 3,137). However, in both approaches, the values were less than one Gross Domestic Product (GDP) per capita of Iran.en
DOIhttps://doi.org/10.22037/ijpr.2017.2046en
KeywordWillingness To Payen
KeywordQuality-Adjusted Life Yearen
KeywordContingent Valuation Methoden
KeywordCost -Effectiveness threshold valueen
KeywordCardiovascular diseasesen
PublisherBrieflandsen
TitleMonetary Value of Quality-Adjusted Life Years (QALY) among Patients with Cardiovascular Disease: a Willingness to Pay Study (WTP)en
TypeOriginal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijpr-16-823.pdf
Size:
440.25 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF
Download

Collections

Iranian Journal of Pharmaceutical Research